Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080347 | SCV000112243 | likely benign | not specified | 2016-01-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000552953 | SCV000647904 | benign | Intellectual disability, CASK-related, X-linked | 2025-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001610366 | SCV001835467 | benign | not provided | 2018-08-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002408606 | SCV002717239 | benign | Inborn genetic diseases | 2017-06-30 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004542771 | SCV004765579 | likely benign | CASK-related disorder | 2024-02-23 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |